Patient-reported benefits of colonoscopicallyadministered microbiota restoration therapy: a qualitative study of adult patients with recurrent <i>Clostridioides difficile</i> infection

Authors

Institutions

Publication Details

Journal
Therapeutic Advances in Gastroenterology
Published
2025-11-01
DOI
https://doi.org/10.1177/17562848251392102
Primary Topic
Clostridium difficile and Clostridium perfringens research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient-reported benefits of colonoscopicallyadministered microbiota restoration therapy: a qualitative study of adult patients with recurrent Clostridioides difficile infection

Cindy Umanzor, Tahany Awad, Beth Guthmueller, Tara L. Symonds et al.
Therapeutic Advances in Gastroenterology
Clostridium difficile and Clostridium perfringens research
article

Patient-reported benefits of colonoscopicallyadministered microbiota restoration therapy: a qualitative study of adult patients with recurrent Clostridioides difficile infection

Cindy Umanzor, Tahany Awad, Beth Guthmueller, Tara L. Symonds, Margarita Landeira, Sahil Khanna, Megan McCool-Myers, Daniel Armandi
article en

Abstract

No abstract available for this paper.
Therapeutic Advances in GastroenterologyVol. 18
Health Outcomes Solutions (United States) (US), Mayo Clinic in Arizona (US), Ferring Pharmaceuticals (Denmark) (DK)
Openalex Percentile: Top 60%
Clostridium difficile and Clostridium perfringens research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.